As part of its mission to catalyze preeclampsia research, the Preeclampsia Foundation has announced a new national health services research collaborative with faculty at Northwestern University in Chicago, the University of North Carolina at Chapel Hill, and the University of Pennsylvania.
The collaborative's first study -- called
Preeclampsia Research Innovation for Maternal Engagement (PRIME for short) -- is intended to improve preeclampsia outcomes by evaluating interventions that engage women more intentionally in their prenatal care.
To support this objective, members of the collaborative will work together to develop and pilot test a remote blood pressure monitoring intervention that utilizes mobile and health information technology to promote the early detection and treatment of preeclampsia.
"We're standing at the cusp of a potential paradigm shift for prenatal care, invoking more home-based monitoring, telemedicine, and other advances that we hope will improve outcomes and reduce costs," said Eleni Tsigas, Chief Executive Officer of the Preeclampsia Foundation. "But we need solid research to determine if these innovations will accomplish their intended goals. All expectant mothers are worthy of optimal care and healthy pregnancy outcomes."
"We have had success using technology to improve the care of women," said Sindhu Srinivas, MD, MSCE Director of Obstetrical Services and Vice Chair for Quality and Safety at the University of Pennsylvania, Department of Obstetrics and Gynecology. Heart Safe Motherhood is a technology-enabled novel intervention that has achieved breakthrough outcomes in the context of keeping new mothers safe once they're discharged from the hospital after being diagnosed with preeclampsia. We have found a high level of patient engagement and a significant reduction in readmissions with this approach. We are looking forward to working with this group to revolutionize antenatal care delivery."
This two-year project will inform at least one subsequent, external grant application to further evaluate the intervention in a large randomized controlled trial and, if found to be effective, enable widespread implementation.